OCT 12, 2015 07:10 PM PDT

Metabolic Engineering in Ten Easy Steps

WRITTEN BY: Kerry Evans
Bacteria have the capacity to produce numerous substances for commercial and industrial applications. Despite this, very few strains are being used on an industrial scale, likely because such “metabolic engineering” requires a hefty investment.  Investigators at the Korea Advanced Institute of Science and Technology (KAIST) estimate that it requires anywhere from 50 to 300 person-years of work (!) and several hundred million dollars to engineer strains and implement their use on a large scale.  To stream-line the process, KAIST researchers Sang Yup Lee and Hyun Uk Kim recently published ten strategies to develop industrial microbial strains.
 
Korean scientists publish ten step "toolkit" for metabolic engineering.


Metabolic engineering seeks to optimize existing pathways in a cell to more efficiently produce a desired metabolite.  Often, this requires some degree of genetic engineering.  Strains of E. coli are already used to produce amino acids such as L-valine, L-lysine, L-arginine, and L-threonine, chemicals such as butanol, and succinic acid, as well as the anti-parasitic drug artemisinin.  Microbes can also be used to produce biofuels such as short-chain and fatty alcohols to replace gasoline and diesel.  

Lee and Kim’s ten strategies guide researchers from choosing the appropriate host strain, to implementing its use on a commercial scale.  They stress first and foremost the need to choose the most economically viable strain, giving special consideration to how easily particular strains can be genetically engineered.  When it comes to reconstructing or optimizing metabolic pathways, they recommend the use of “chemo-bioinformatic” tools to construct the most efficient pathways.  They also recommend removing any feedback inhibition controls that could diminish the amount of metabolite produced.  Another important consideration is how well the bacteria will tolerate the overproduction of certain metabolites, so called “product tolerance”.  It may be possible to greatly increase the amount of product made, but this may also inhibit the bacteria’s growth.  A final step in the development process is to ensure that engineered strains can be grown on a commercial scale, since oxygen and other nutrients can become limiting factors in large-scale cultures.            

According to Lee, “At the moment, the chance of commercializing microbial strains developed in academic labs is very low...We hope that these strategies contribute to improving opportunities to commercializing microbial strains developed in academic labs with drastically reduced costs and efforts, and that a large fraction of petroleum-based processes will be replaced with sustainable bioprocesses”.

Sources: Eurekalert, Nature Biotechnology, Wikipedia
 
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
SEP 29, 2018
Microbiology
SEP 29, 2018
In a First, Rat Variation of Hepatitis E Found in a Person
It was found in a 56-year-old Hong Kong man....
SEP 29, 2018
Videos
SEP 29, 2018
How Researchers Study the Microbes in the Human Gut
Researchers are starting to learn a lot more about the huge number of microbes living in our gastrointestinal tract. But how?...
SEP 30, 2018
Microbiology
SEP 30, 2018
These Microscopic Things Elude Our Eyes Every Day
We take much of what we can see for granted, but if your eyes had the observational power of a microscope, you’d probably look at the world very diff...
SEP 30, 2018
Drug Discovery
SEP 30, 2018
Researchers Re-classify the 'Magic Mushroom' Drug
Researchers at John Hopkins have evaluated the safety and efficacy of compound, psilocybin, found in hallucinogenic mushrooms. They suggested that if evalu...
DEC 10, 2018
Microbiology
DEC 10, 2018
The 'Deep Biosphere' of the Earth Teems with Life
Deep within the surface of the earth lies a gargantuan amount of carbon in the form of various types of microbial life....
DEC 11, 2018
Genetics & Genomics
DEC 11, 2018
Dust with High Levels of Triclosan has More Antibiotic Resistance Genes
Researchers have found that some dust contains high amounts of a common antimicrobial agent called triclosan....
Loading Comments...